One vision —
a cancer-free future.
Unlike surgery, chemotherapy and radiation, cell and gene therapies harness the power of your immune system to destroy cancer cells without harming healthy tissue. We fund the research that will make this vision a reality.
Kymriah's 5-year survival data shows promise of CAR T cells
Nearly half of blood cancer patients who received Kymriah CAR T-cell therapy reached five years of survival.
Scientists find new CAR T-cell target for ovarian cancer and lung cancer
The discovery of the protein expressed on both lung tumors and ovarian tumors may help lead to a CAR T-cell therapy for both cancers.
An explanation of gene therapy for cancer
What exactly is gene therapy for cancer? How is gene therapy is used to treat cancer, and what are the types of gene therapy and steps patients go through for treatment?
Top 3 challenges for cell and gene therapy against solid tumors
Solid tumors pose unique challenges to using cell and gene therapy. There are solutions, though.
Our direct impact on eradicating all cancer.
Collaborating with partners and funding research fellows, we are transforming cancer treatments today while bringing the world closer to a cure for all cancers tomorrow.
31.5
million dollars awarded to groundbreaking research.
61
research fellows supported.
36
of the top medical institutions funded.
Join forces with the world’s leading researchers to finally identify cures.
Cell and gene therapies harness the power of a patient’s own immune system to destroy cancer cells without harming healthy tissue.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Matthias Stephan, MD, PhD
Fred Hutchinson Cancer Research Center
Advancing pre-clinical strategies that combine principles of bioengineering with gene therapy to improve the effectiveness of therapeutic cancer vaccines.
Brian Brown, PhD
Icahn School of Medicine at Mount Sinai
Working to harness the power of gene therapy to equip a patient’s own T cells to kill immune-suppressing cells.
Sidi Chen, PhD
Yale University School of Medicine
Taking on the challenges of pancreatic cancer with an innovative, versatile and highly scalable CRISPRa strategy.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Matthias Stephan, MD, PhD
Fred Hutchinson Cancer Research Center
Advancing pre-clinical strategies that combine principles of bioengineering with gene therapy to improve the effectiveness of therapeutic cancer vaccines.
Brian Brown, PhD
Icahn School of Medicine at Mount Sinai
Working to harness the power of gene therapy to equip a patient’s own T cells to kill immune-suppressing cells.
Sidi Chen, PhD
Yale University School of Medicine
Taking on the challenges of pancreatic cancer with an innovative, versatile and highly scalable CRISPRa strategy.
Stay up-to-date with us and get involved.
100% of your donation will advance research to cure all cancers.
Your donation will help develop radical new cell and gene therapies that leverage the body’s own biology and immune system to control and ultimately eradicate cancer. 100% of donations directly support scientists working on breakthrough cancer cell and gene therapy research.
Donate Today